Biography
Meredith Mackey is a partner in Weil’s Banking & Finance practice and is based in New York. Her practice involves advising institutional lenders, direct lenders and underwriters on all types of bank finance and securities transactions, with a particular focus on leveraged loans and high-yield debt. Meredith also has significant experience advising on acquisition financings, bridge loans, restructurings and subordinated and second lien financings.
Meredith is recognized by Chambers USA in Banking & Finance and by Legal 500 in Capital Markets: Equity Offerings and High-Yield Debt Offerings, and has been recognized in Finance: Commercial Lending. She was named to Crain’s New York Business’s list of “100 Notable Women” in 2021.
Prior to joining Weil, Meredith was a partner at another international law firm and also served as Vice President at Goldman Sachs’ Loan Negotiations Group.
Experience*
- A syndicate of initial purchasers, led by Citigroup Global Markets and Goldman Sachs & Co. LLC, in Clarivate’s $1 billion offering of 3.875% high-yield senior secured notes due 2028 and $1 billion offering of 4.875% senior notes due 2029, each related to Clarivate’s proposed acquisition of ProQuest LLC and its consolidated subsidiaries.
- Royal Bank of Canada as lead arranger and administrative agent in connection with a $500 million revolving credit facility provided to Spectrum Brands, Inc.
- Jefferies Finance LLC, Blackstone Alternative Credit Advisors LP, MidCap Financial Trust, UBS Securities LLC and Credit Agricole Corporate and Investment Bank, as lead arrangers in connection with financing related to the acquisition of Natus Medical Incorporated by ArchiMed SAS. The financing included a $412 million term loan B and a $50 million revolving credit facility, with Jefferies Finance LLC as administrative agent.
- Antares Capital LP in a $435 million first lien term loan facility, a $160 million second lien term loan facility and a $75 million first lien revolving credit facility to finance the acquisition of Protective Industrial Products Inc. by Odyssey Investment Partners.
*Matters noted above include those handled prior to joining Weil.